Does walking during chemotherapy impact p16INK4a levels in women with early breast cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24753
Abstract: Increased p16INK4a (p16) expression is directly related to cellular senescence and is a robust biomarker of aging in humans. Prior studies have shown that levels of p16 dramatically increase in breast cancer patients who have… read more here.
Keywords: p16ink4a; walking chemotherapy; impact p16ink4a; chemotherapy impact ... See more keywords